Learn / CRL
NYSE: CRL
Charles River Laboratories International (CRL) stock, explained like you're 5
Charles River Laboratories International trades on the New York Stock Exchange under the ticker CRL. It is a large cap company in the commercial physical & biological resarch industry, part of the healthcare sector, with a market value of about 14.4 billion dollars.
- Ticker
- CRL
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Commercial Physical & Biological Resarch
- Size
- Large cap, about 14.4 billion dollars
Is Charles River Laboratories International a small, medium or large cap company?
Yes. Charles River Laboratories International is a large cap stock. Its market cap, which is the total value of all its shares, is about 14.4 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Charles River Laboratories International makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves CRL stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Charles River Laboratories Inte (CRL) Stock Forecasts (Yahoo! Finance Canada)
- Charles River Laboratories International Inc. stock outperforms competitors despite losses on the day (MarketWatch)
- Charles River Laboratories International (CRL) Earnings Beat Puts Fair Value Back In Focus (Simply Wall Street)
- Over $300 million in savings is expected as Charles River automates and simplifies work, 2027 30. (Stock Titan)
- Drug Development Inputs & Services Stocks Q2 In Review: Charles River Laboratories (NYSE:CRL) Vs Peers (TradingView)
Follow CRL in your daily brief
Each trading day at 5 PM ET we post what happened to Charles River Laboratories International and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow CRL
Questions about Charles River Laboratories International stock
What does Charles River Laboratories International do?
Charles River Laboratories International trades on the New York Stock Exchange under the ticker CRL. It is a large cap company in the commercial physical & biological resarch industry, part of the healthcare sector, with a market value of about 14.4 billion dollars.
What is the ticker symbol for Charles River Laboratories International?
Charles River Laboratories International trades under the ticker CRL on the New York Stock Exchange.
What is Charles River Laboratories International's market cap?
Charles River Laboratories International is a large cap stock with a market cap of about 14.4 billion dollars.
How does Charles River Laboratories International make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves CRL stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow CRL stock every day?
Add CRL to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.